SIGLEC15 (sialic acid-binding immunoglobulin-type lectin 15) is an emerging immunosuppressive transmembrane protein that is highly expressed in various solid tumors, including pancreatic cancer, thyroid cancer, bladder cancer, and glioma. This evidence concerns the gene SIGLEC15 and urinary bladder cancer.